Cleary Gottlieb Steen & Hamilton has advised GlaxoSmithKline (GSK) on a $3.6bn (£2.5bn) buyout as the pharma giant completes its second major deal in a week. The firm acted for regular client GSK on its acquisition of dermatology specialist Stiefel Laboratories in a deal announced today (20 April).Cleary's New York-based team was led by corporate partner Benet O'Reilly, alongside tax partner Sheldon Alster, employee benefits partner Arthur Kohn, real estate partner Kimberly Brown Blacklow and antitrust partner David Gelfand.
April 20, 2009 at 12:33 PM
1 minute read
The original version of this story was published on Legalweek
Cleary Gottlieb Steen & Hamilton has advised GlaxoSmithKline (GSK) on a $3.6bn (£2.5bn) buyout as the pharma giant completes its second major deal in a week.
The firm acted for regular client GSK on its acquisition of dermatology specialist Stiefel Laboratories in a deal announced today (20 April).
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
